• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Syndecan-3 作为阿尔茨海默病的新型生物标志物。

Syndecan-3 as a Novel Biomarker in Alzheimer's Disease.

机构信息

Pharmacoidea Ltd., H-6726 Szeged, Hungary.

Albert Szent-Györgyi Clinical Center, Department of Medicine, Faculty of Medicine, University of Szeged, H-6720 Szeged, Hungary.

出版信息

Int J Mol Sci. 2022 Mar 21;23(6):3407. doi: 10.3390/ijms23063407.

DOI:10.3390/ijms23063407
PMID:35328830
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8955174/
Abstract

Early diagnosis of Alzheimer's disease (AD) is of paramount importance in preserving the patient's mental and physical health in a fairly manageable condition for a longer period. Reliable AD detection requires novel biomarkers indicating central nervous system (CNS) degeneration in the periphery. Members of the syndecan family of transmembrane proteoglycans are emerging new targets in inflammatory and neurodegenerative disorders. Reviewing the growing scientific evidence on the involvement of syndecans in the pathomechanism of AD, we analyzed the expression of the neuronal syndecan, syndecan-3 (SDC3), in experimental models of neurodegeneration. Initial in vitro studies showed that prolonged treatment of tumor necrosis factor-alpha (TNF-α) increases SDC3 expression in model neuronal and brain microvascular endothelial cell lines. In vivo studies revealed elevated concentrations of TNF-α in the blood and brain of APPSWE-Tau transgenic mice, along with increased SDC3 concentration in the brain and the liver. Primary brain endothelial cells and peripheral blood monocytes isolated from APPSWE-Tau mice exhibited increased SDC3 expression than wild-type controls. SDC3 expression of blood-derived monocytes showed a positive correlation with amyloid plaque load in the brain, demonstrating that SDC3 on monocytes is a good indicator of amyloid pathology in the brain. Given the well-established role of blood tests, the SDC3 expression of monocytes could serve as a novel biomarker for early AD detection.

摘要

早期诊断阿尔茨海默病(AD)对于在相当可管理的条件下延长患者的身心健康非常重要。可靠的 AD 检测需要新的生物标志物来指示中枢神经系统(CNS)在周围的退化。细胞表面蛋白聚糖的 syndecan 家族成员是炎症和神经退行性疾病的新兴新靶点。在回顾 syndecan 参与 AD 发病机制的不断增加的科学证据的基础上,我们分析了神经元 syndecan-3(SDC3)在神经退行性变实验模型中的表达。最初的体外研究表明,肿瘤坏死因子-α(TNF-α)的长期治疗会增加模型神经元和脑微血管内皮细胞系中 SDC3 的表达。体内研究显示,APPSWE-Tau 转基因小鼠的血液和大脑中 TNF-α 浓度升高,大脑和肝脏中 SDC3 浓度升高。从 APPSWE-Tau 小鼠中分离出的原代脑内皮细胞和外周血单核细胞表现出比野生型对照更高的 SDC3 表达。血液衍生单核细胞的 SDC3 表达与大脑中的淀粉样斑块负荷呈正相关,表明单核细胞上的 SDC3 是大脑中淀粉样蛋白病理学的良好指标。鉴于血液检测的既定作用,单核细胞的 SDC3 表达可以作为早期 AD 检测的新型生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c09/8955174/9b06c6fbb024/ijms-23-03407-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c09/8955174/ef5a013fdaa3/ijms-23-03407-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c09/8955174/b965574fcd88/ijms-23-03407-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c09/8955174/da594494f571/ijms-23-03407-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c09/8955174/fc6e7132c277/ijms-23-03407-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c09/8955174/f42a6b2a4d30/ijms-23-03407-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c09/8955174/9b06c6fbb024/ijms-23-03407-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c09/8955174/ef5a013fdaa3/ijms-23-03407-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c09/8955174/b965574fcd88/ijms-23-03407-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c09/8955174/da594494f571/ijms-23-03407-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c09/8955174/fc6e7132c277/ijms-23-03407-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c09/8955174/f42a6b2a4d30/ijms-23-03407-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c09/8955174/9b06c6fbb024/ijms-23-03407-g006.jpg

相似文献

1
Syndecan-3 as a Novel Biomarker in Alzheimer's Disease.Syndecan-3 作为阿尔茨海默病的新型生物标志物。
Int J Mol Sci. 2022 Mar 21;23(6):3407. doi: 10.3390/ijms23063407.
2
Distinct effects of SDC3 and FGFRL1 on selective neurodegeneration in AD and PD.SDC3和FGFRL1对阿尔茨海默病和帕金森病中选择性神经变性的不同影响。
FASEB J. 2023 Feb;37(2):e22773. doi: 10.1096/fj.202201359R.
3
Peripheral Tumor Necrosis Factor-Alpha (TNF-α) Modulates Amyloid Pathology by Regulating Blood-Derived Immune Cells and Glial Response in the Brain of AD/TNF Transgenic Mice.外周肿瘤坏死因子-α(TNF-α)通过调节AD/TNF转基因小鼠大脑中源自血液的免疫细胞和神经胶质反应来调节淀粉样蛋白病理学。
J Neurosci. 2017 May 17;37(20):5155-5171. doi: 10.1523/JNEUROSCI.2484-16.2017. Epub 2017 Apr 25.
4
Heparan sulfate accumulation with Abeta deposits in Alzheimer's disease and Tg2576 mice is contributed by glial cells.在阿尔茨海默病和Tg2576小鼠中,硫酸乙酰肝素与β淀粉样蛋白沉积的积累是由神经胶质细胞造成的。
Brain Pathol. 2008 Oct;18(4):548-61. doi: 10.1111/j.1750-3639.2008.00152.x. Epub 2008 Apr 11.
5
Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease.外周衍生血管紧张素转换酶增强型巨噬细胞缓解阿尔茨海默病相关疾病。
Brain. 2020 Jan 1;143(1):336-358. doi: 10.1093/brain/awz364.
6
Contribution of syndecans to cellular internalization and fibrillation of amyloid-β(1-42).黏附素对淀粉样β(1-42)细胞内化和纤维形成的贡献。
Sci Rep. 2019 Feb 4;9(1):1393. doi: 10.1038/s41598-018-37476-9.
7
Oleracone F Alleviates Cognitive Impairment and Neuropathology in APPswe/PSEN1dE9 Mice by Reducing the Expression of Vascular Cell Adhesion Molecule and Leukocyte Adhesion to Brain Vascular Endothelial Cells.Oleracone F 通过降低血管细胞黏附分子和白细胞黏附至脑微血管内皮细胞的表达水平减轻 APPswe/PSEN1dE9 小鼠的认知障碍和神经病理学损伤。
Int J Mol Sci. 2023 Jan 20;24(3):2056. doi: 10.3390/ijms24032056.
8
The Interplay of Apoes with Syndecans in Influencing Key Cellular Events of Amyloid Pathology.载脂蛋白与 syndecans 在影响淀粉样变病理学关键细胞事件中的相互作用。
Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.
9
Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?CX3CR1和趋化因子在阿尔茨海默病(AD)啮齿动物模型中对β淀粉样蛋白清除及磷酸化tau蛋白积累的影响:趋化因子是AD的全身性生物标志物吗?
Curr Alzheimer Res. 2016;13(4):403-12. doi: 10.2174/1567205013666151116125714.
10
Increased Type I interferon signaling and brain endothelial barrier dysfunction in an experimental model of Alzheimer's disease.阿尔茨海默病实验模型中 I 型干扰素信号转导增强和脑内皮屏障功能障碍。
Sci Rep. 2022 Oct 1;12(1):16488. doi: 10.1038/s41598-022-20889-y.

引用本文的文献

1
Peripheral Leukocyte Syndecan-3 Is Elevated in Alzheimer's Disease: Evidence from a Human Study.外周血白细胞Syndecan-3在阿尔茨海默病中升高:一项人体研究的证据。
Int J Mol Sci. 2025 Jul 9;26(14):6587. doi: 10.3390/ijms26146587.
2
Proteoglycans are protagonists in autophagy, lymphangiogenesis, and neurodegenerative diseases.蛋白聚糖在自噬、淋巴管生成和神经退行性疾病中起主要作用。
Trends Cell Biol. 2025 Jul 10. doi: 10.1016/j.tcb.2025.06.002.
3
Co-Aggregation of Syndecan-3 with β-Amyloid Aggravates Neuroinflammation and Cognitive Impairment in 5×FAD Mice.

本文引用的文献

1
The Unifying Hypothesis of Alzheimer's Disease: Heparan Sulfate Proteoglycans/Glycosaminoglycans Are Key as First Hypothesized Over 30 Years Ago.阿尔茨海默病的统一假说:硫酸乙酰肝素蛋白聚糖/糖胺聚糖如30多年前所首次假设的那样是关键因素。
Front Aging Neurosci. 2021 Oct 4;13:710683. doi: 10.3389/fnagi.2021.710683. eCollection 2021.
2
The Interplay of Apoes with Syndecans in Influencing Key Cellular Events of Amyloid Pathology.载脂蛋白与 syndecans 在影响淀粉样变病理学关键细胞事件中的相互作用。
Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.
3
Hyperactivation of monocytes and macrophages in MCI patients contributes to the progression of Alzheimer's disease.
Syndecan-3与β-淀粉样蛋白的共聚集加重5×FAD小鼠的神经炎症和认知障碍。
Int J Mol Sci. 2025 Jun 8;26(12):5502. doi: 10.3390/ijms26125502.
4
Shed Syndecans (1-3), ELA-32, BDNF, NLR, and hs-CRP in Parkinson's Disease: Appropriate Diagnostic and Prognostic Biomarkers When Combined in a Unique Panel.帕金森病中的脱落 Syndecans(1 - 3)、ELA - 32、脑源性神经营养因子、中性粒细胞与淋巴细胞比值及高敏 C 反应蛋白:联合纳入独特检测组时作为合适的诊断和预后生物标志物
Int J Mol Sci. 2025 May 8;26(10):4503. doi: 10.3390/ijms26104503.
5
Endocytic Pathways Unveil the Role of Syndecans in the Seeding and Spreading of Pathological Protein Aggregates: Insights into Neurodegenerative Disorders.内吞途径揭示了聚糖在病理性蛋白质聚集体的播种和传播中的作用:对神经退行性疾病的见解。
Int J Mol Sci. 2025 Apr 24;26(9):4037. doi: 10.3390/ijms26094037.
6
c-Triadem: A constrained, explainable deep learning model to identify novel biomarkers in Alzheimer's disease.c-三元组:一种用于识别阿尔茨海默病新生物标志物的受限可解释深度学习模型。
PLoS One. 2025 Apr 14;20(4):e0320360. doi: 10.1371/journal.pone.0320360. eCollection 2025.
7
Sleep-wake variation in body temperature regulates tau secretion and correlates with CSF and plasma tau.体温的睡眠-觉醒变化调节tau蛋白分泌,并与脑脊液和血浆中的tau蛋白相关。
J Clin Invest. 2025 Feb 4;135(7):e182931. doi: 10.1172/JCI182931.
8
Syndecans in Alzheimer's disease: pathogenetic mechanisms and potential therapeutic targets.阿尔茨海默病中的 Syndecans:发病机制及潜在治疗靶点
Neural Regen Res. 2025 Sep 1;20(9):2594-2595. doi: 10.4103/NRR.NRR-D-24-00659. Epub 2024 Sep 24.
9
The Glycocalyx: The Importance of Sugar Coating the Blood-Brain Barrier.糖萼:血脑屏障的重要性。
Int J Mol Sci. 2024 Aug 1;25(15):8404. doi: 10.3390/ijms25158404.
10
What Are the Reliable Plasma Biomarkers for Mild Cognitive Impairment? A Clinical 4D Proteomics Study and Validation.哪些是轻度认知障碍的可靠血浆生物标志物?一项临床 4D 蛋白质组学研究及验证。
Mediators Inflamm. 2024 May 27;2024:7709277. doi: 10.1155/2024/7709277. eCollection 2024.
轻度认知障碍(MCI)患者单核细胞和巨噬细胞的过度激活会促使阿尔茨海默病的进展。
Immun Ageing. 2021 Jun 21;18(1):29. doi: 10.1186/s12979-021-00236-x.
4
Diagnosis of Early Alzheimer's Disease: Clinical Practice in 2021.早期阿尔茨海默病的诊断:2021 年的临床实践。
J Prev Alzheimers Dis. 2021;8(3):371-386. doi: 10.14283/jpad.2021.23.
5
Alzheimer disease.阿尔茨海默病。
Nat Rev Dis Primers. 2021 May 13;7(1):33. doi: 10.1038/s41572-021-00269-y.
6
2021 Alzheimer's disease facts and figures.2021 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2021 Mar;17(3):327-406. doi: 10.1002/alz.12328. Epub 2021 Mar 23.
7
Alzheimer's disease: many failed trials, so where do we go from here?阿尔茨海默病:多项试验失败,我们该何去何从?
J Investig Med. 2020 Aug;68(6):1135-1140. doi: 10.1136/jim-2020-001297. Epub 2020 Jul 21.
8
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease.阿尔茨海默病发病机制的分子和细胞机制
Mol Neurodegener. 2020 Jul 16;15(1):40. doi: 10.1186/s13024-020-00391-7.
9
Relevance of biomarkers across different neurodegenerative diseases.生物标志物在不同神经退行性疾病中的相关性。
Alzheimers Res Ther. 2020 May 13;12(1):56. doi: 10.1186/s13195-020-00601-w.
10
Syndecans in Inflammation at a Glance.黏附素在炎症中的作用概览。
Front Immunol. 2020 Feb 18;11:227. doi: 10.3389/fimmu.2020.00227. eCollection 2020.